RT Journal Article
T1 Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe
A1 Thorne, Claire
A1 Turkova, Anna
A1 Indolfi, Giuseppe
A1 Venturini, Elisabetta
A1 Giaquinto, Carlo
A1 Goetghebuer, Tessa
A1 Hainaut, Marc
A1 Van der Kelen, Evelyne
A1 Koenigs, Christoph
A1 Mantzsch, Kathleen
A1 Baumann, Ulrich
A1 de Martino, Maurizio
A1 Galli, Luisa
A1 Giacomet, Vania
A1 Nicolini, Laura Ambra
A1 Del Puente, Filippo
A1 Gabiano, Clara
A1 Guarino, Alfredo
A1 Martinazzi, Silvia
A1 Miniaci, Angela
A1 Dobsz, Sabina
A1 Marczynska, Magdalena
A1 Ene, Luminita
A1 Duiculescu, Dan
A1 Miloenko, Milana
A1 Dodonov, Konstantin
A1 Latysheva, Inga
A1 Voronin, Evgeny
A1 Rojo, Pablo
A1 Tomas Ramos, Jose
A1 Navarro, Marisa
A1 Jimenez de Ory, Santiago
A1 Sainz, Talia
A1 Mellado, Maria J.
A1 Garcia, Miluca
A1 Perez, Carlos
A1 Moreno, David
A1 Nunez, Esmeralda
A1 Gracia, Mercedes
A1 Terol, Pedro
A1 Neth, Olaf
A1 Falcon, Lola
A1 Otero, Carmen
A1 Rincon, Elena
A1 Lopez, Carmen
A1 Luis Santos, Juan
A1 Couceiro, Jose
A1 Noguera-Julian, Antoni
A1 Fortuny, Claudia
A1 Soler-Palacin, Pere
A1 Espiau, Maria
A1 Mur, Antonio
A1 Coll, Maria T.
A1 Valmanya, Maria T.
A1 Mayol, Luis
A1 Mendez, Maria J.
A1 Rodrigo, Carlos
A1 Escribano, Joaquin
A1 Rius, Neus
A1 Rovira, Nuria
A1 Calavia, Olga
A1 Garcia, Lourdes
A1 Pineda, Valenti
A1 Soriano-Arandes, Antoni
A1 Rudin, Christoph
A1 Duppenthaler, Andrea
A1 Judd, Ali
A1 Malyuta, Ruslan
A1 Volokha, Alla
A1 Raus, Irina
A1 Kaleeva, T.
A1 Baryshnikova, Y.
A1 Soloha, Svetlana
A1 Bashkatova, N.
A1 Glutshenko, O.
A1 Ruban, Z.
A1 Primak, Natalia
A1 Kiseleva, Galina
A1 European Paediat HIV HCV, 
K1 coinfection
K1 hepatitis C
K1 HIV
K1 paediatric
K1 vertical infection
K1 Human-immunodeficiency-virus
K1 Simple noninvasive index
K1 Antiretroviral therapy
K1 Pegylated interferon
K1 Fibrosis progression
K1 St-petersburg
K1 Liver
K1 Impact
K1 Transmission
K1 Adolescents
AB Objective:To characterize children, adolescents and young adults infected with HIV/hepatitis C virus (HCV) vertically or before age of 18 years and living in Europe regarding mode of acquisition, HCV genotype, clinical status and treatment.Design:Retrospective, cross-sectional study using pooled data from 11 European paediatric HIV cohorts.Methods:Patients aged more than 18 months and less than 25 years, with HIV/HCV acquired vertically or in childhood, were included. Anonymized individual patient data were collected using a standard protocol and modified HIV Cohorts Data Exchange Protocol.Results:Of 229 patients included, 142 (62%) had vertically acquired infection. Median age at last follow-up was 16.2 years. Most children had HCV genotype 1 (101/184, 55%) or 3 (57/184, 31%). One-fifth (46/214) had a previous AIDS diagnosis (data missing on prior AIDS diagnoses for 15). At their last clinic visit, 70% (145/208) had no/mild immunosuppression (Centers for Disease Control and Prevention stage 1), and 131 of 179 on antiretroviral therapy had undetectable HIV RNA (assay thresholds varied from
PB Lippincott williams & wilkins
SN 0269-9370
YR 2017
FD 2017-01-02
LK https://hdl.handle.net/10668/26391
UL https://hdl.handle.net/10668/26391
LA en
DS RISalud
RD Apr 12, 2025